http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Takehisa Watanabe (검색결과 2 건)
- 무료
- 기관 내 무료
- 유료
-
Yujiro Ichikawa,Takehisa Watanabe,Yasuhide Horimoto,Katsumi Ishii,Suekazu Naito 한국대기환경학회 2018 Asian Journal of Atmospheric Environment (AJAE) Vol.12 No.3
Quantitative data of 50 non-polar organic compounds constituting PM2.5 were continuously collected and analyzed from June 2016 to October 2017 (approximately 17 months) at Ichihara, one of the largest industrial areas in Japan. Target nonpolar organic compounds including 21 species of polycyclic aromatic hydrocarbons (PAHs), 24 species of n-alkanes and 5 species of phthalate esters (PAEs) were simultaneously measured by gas chromatography/mass spectrometry. Basically, the average concentrations of the total PAHs, n-alkanes and PAEs in each season remained nearly level, and seasonal variations were little throughout the study period. These results suggest that the emission sources, which are not influenced by the seasons, are the dominant inputs for the target organic compounds. Diagnostic ratios of PAHs, assessment of n-alkane homologue distributions, carbon preference index, and the contribution of wax n-alkanes from plants were used to estimate source apportionments. These results indicate that anthropogenic sources were the main contributor for most PAHs and n-alkanes throughout the study period. The concentrations of PAEs selected in this study were low because emission amounts of these chemicals were little within the source areas of the sampling site. To our knowledge, this study is the first attempt to simultaneously measure a high number of non-polar organic compounds in PM2.5 collected from the ambient air of Japan, and the resultant data will provide valuable data and information for environmental researchers.
-
Takako Inoue,Takehisa Watanabe,Yasuhito Tanaka 대한간학회 2023 Clinical and Molecular Hepatology(대한간학회지) Vol.29 No.4
The current requirement for biomarkers to detect hepatitis B virus (HBV) infection is polarized. One is a fully-automated and highly sensitive measurement system; the other is a simple system for point-of-care testing (POCT) in resource-limited areas. Hepatitis B core-related antigen (HBcrAg) reflects intrahepatic covalently closed circular DNA and serum HBV DNA. Even in patients with undetectable serum HBV DNA or HBsAg loss, HBcrAg may remain detectable. Decreased HBcrAg levels are associated with reduction of the occurrence of hepatocellular carcinoma (HCC) in chronic hepatitis B. Recently, a fully-automated, novel high-sensitivity HBcrAg assay (iTACT-HBcrAg, cut-off value: 2.1 logIU/mL) has been developed. This attractive assay has been released in Japan very recently. iTACT-HBcrAg can be useful for monitoring HBV reactivation and prediction of HCC occurrence, as an alternative to HBV DNA. Moreover, monitoring HBcrAg may be suitable for determining the therapeutic effectiveness of approved drugs and novel drugs under development. Presently, international guidelines recommend anti-HBV prophylaxis for pregnant women with high viral loads to prevent mother-to-child transmission of HBV. However, >95% of HBV-infected individuals live in countries where HBV DNA quantification is not available. Worldwide elimination of HBV needs the scaling-up of examination and medication services in resource-limited areas. Based on this situation, a rapid and easy HBcrAg assay as a POCT is valuable. This review provides the latest information regarding the clinical use of a new surrogate marker, HBcrAg, in HBV management, based on iTACT-HBcrAg or POCT, and introduces novel agents targeting HBV RNA/protein.
DBpia
ScienceON연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
